Clinical Trial Update: Protective Effect of EPA on Cardiovascular Events [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting on the potential protective effect of eicosapentaenoic acid (EPA) against cardiovascular events. The study includes outc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Peripheral Artery Disease
• Stroke
• Sudden Cardiac Death
• Unstable Angina

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Kobe University | Conditions: Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease | Phase 4 | Status: COMPLETED